GB0012233D0 - Vector constructs - Google Patents

Vector constructs

Info

Publication number
GB0012233D0
GB0012233D0 GBGB0012233.3A GB0012233A GB0012233D0 GB 0012233 D0 GB0012233 D0 GB 0012233D0 GB 0012233 A GB0012233 A GB 0012233A GB 0012233 D0 GB0012233 D0 GB 0012233D0
Authority
GB
United Kingdom
Prior art keywords
vector constructs
constructs
expression
double
stranded rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0012233.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Devgen NV
Original Assignee
Devgen NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9891999&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB0012233(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Devgen NV filed Critical Devgen NV
Priority to GBGB0012233.3A priority Critical patent/GB0012233D0/en
Publication of GB0012233D0 publication Critical patent/GB0012233D0/en
Priority to DE60126760T priority patent/DE60126760T2/de
Priority to AT07000056T priority patent/ATE492638T1/de
Priority to JP2001585328A priority patent/JP5153983B2/ja
Priority to AU2001264166A priority patent/AU2001264166A1/en
Priority to AT01938492T priority patent/ATE354652T1/de
Priority to DE60143718T priority patent/DE60143718D1/de
Priority to PCT/IB2001/001068 priority patent/WO2001088121A1/en
Priority to GB0112213A priority patent/GB2365867B/en
Priority to EP01938492A priority patent/EP1285062B1/en
Priority to ES07000056T priority patent/ES2356389T3/es
Priority to ES01938492T priority patent/ES2281420T3/es
Priority to EP07000056A priority patent/EP1775345B1/en
Priority to US09/860,763 priority patent/US7358069B2/en
Priority to US12/055,607 priority patent/US7932062B2/en
Priority to JP2012151889A priority patent/JP5645886B2/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Optical Communication System (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Inductance-Capacitance Distribution Constants And Capacitance-Resistance Oscillators (AREA)
  • Control Of Ac Motors In General (AREA)
  • Soft Magnetic Materials (AREA)
GBGB0012233.3A 2000-05-19 2000-05-19 Vector constructs Ceased GB0012233D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB0012233.3A GB0012233D0 (en) 2000-05-19 2000-05-19 Vector constructs
EP07000056A EP1775345B1 (en) 2000-05-19 2001-05-18 Vector constructs
US09/860,763 US7358069B2 (en) 2000-05-19 2001-05-18 Vector constructs
PCT/IB2001/001068 WO2001088121A1 (en) 2000-05-19 2001-05-18 Vector constructs
GB0112213A GB2365867B (en) 2000-05-19 2001-05-18 Vector constructs
JP2001585328A JP5153983B2 (ja) 2000-05-19 2001-05-18 ベクター構築物
AU2001264166A AU2001264166A1 (en) 2000-05-19 2001-05-18 Vector constructs
AT01938492T ATE354652T1 (de) 2000-05-19 2001-05-18 Vektorkonstrukte
DE60143718T DE60143718D1 (de) 2000-05-19 2001-05-18 Vektorkonstruktionen
DE60126760T DE60126760T2 (de) 2000-05-19 2001-05-18 Vektorkonstrukte
AT07000056T ATE492638T1 (de) 2000-05-19 2001-05-18 Vektorkonstruktionen
EP01938492A EP1285062B1 (en) 2000-05-19 2001-05-18 Vector constructs
ES07000056T ES2356389T3 (es) 2000-05-19 2001-05-18 Constructos de vectores.
ES01938492T ES2281420T3 (es) 2000-05-19 2001-05-18 Construcciones de vector.
US12/055,607 US7932062B2 (en) 2000-05-19 2008-03-26 Vector constructs
JP2012151889A JP5645886B2 (ja) 2000-05-19 2012-07-05 ベクター構築物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0012233.3A GB0012233D0 (en) 2000-05-19 2000-05-19 Vector constructs

Publications (1)

Publication Number Publication Date
GB0012233D0 true GB0012233D0 (en) 2000-07-12

Family

ID=9891999

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0012233.3A Ceased GB0012233D0 (en) 2000-05-19 2000-05-19 Vector constructs
GB0112213A Expired - Fee Related GB2365867B (en) 2000-05-19 2001-05-18 Vector constructs

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0112213A Expired - Fee Related GB2365867B (en) 2000-05-19 2001-05-18 Vector constructs

Country Status (9)

Country Link
US (2) US7358069B2 (cg-RX-API-DMAC7.html)
EP (2) EP1285062B1 (cg-RX-API-DMAC7.html)
JP (2) JP5153983B2 (cg-RX-API-DMAC7.html)
AT (2) ATE354652T1 (cg-RX-API-DMAC7.html)
AU (1) AU2001264166A1 (cg-RX-API-DMAC7.html)
DE (2) DE60126760T2 (cg-RX-API-DMAC7.html)
ES (2) ES2356389T3 (cg-RX-API-DMAC7.html)
GB (2) GB0012233D0 (cg-RX-API-DMAC7.html)
WO (1) WO2001088121A1 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0012233D0 (en) * 2000-05-19 2000-07-12 Devgen Nv Vector constructs
US7612194B2 (en) * 2001-07-24 2009-11-03 Monsanto Technology Llc Nucleic acid sequences from Diabrotica virgifera virgifera LeConte and uses thereof
US20040180438A1 (en) 2002-04-26 2004-09-16 Pachuk Catherine J. Methods and compositions for silencing genes without inducing toxicity
AU2003239851A1 (en) * 2002-05-08 2003-11-11 Xantos Biomedicine Ag Expression constructs for producing double-stranded (ds) rna and the use thereof
US20040121353A1 (en) 2002-05-23 2004-06-24 Ceptyr, Inc. Modulation of TCPTP signal transduction by RNA interference
MXPA04011624A (es) 2002-05-24 2005-03-07 Schering Corp Anticuerpo neutralizante humano anti-igfr.
WO2004001044A1 (en) * 2002-06-21 2003-12-31 Sinogenomax Company Ltd. Randomised dna libraries and double-stranded rna libraries, use and method of production thereof
US20050196862A1 (en) * 2002-08-30 2005-09-08 Wooddell Christine I. DNA cassette for cellular expression of small RNA
EP1694850B1 (en) 2003-11-12 2011-06-29 Schering Corporation Plasmid system for multigene expression
AR046639A1 (es) 2003-11-21 2005-12-14 Schering Corp Combinaciones terapeuticas de anticuerpo anti- igfr1
ES2547381T3 (es) 2004-04-09 2015-10-05 Monsanto Technology, Llc Composiciones y procedimientos de control de infestaciones de insectos en plantas
PL2444497T3 (pl) * 2004-09-24 2015-04-30 Simplot Co J R Wyciszanie genów
NZ582988A (en) 2004-10-21 2011-07-29 Venganza Inc Methods and materials for conferring resistance to pests and pathogens of plants
EP1807520B1 (en) 2004-10-25 2012-07-25 Devgen NV Rna constructs
US20060242736A1 (en) 2004-12-23 2006-10-26 Shihshieh Huang Dissimilar promoters for gene suppression
CA2610644A1 (en) 2005-05-31 2006-12-07 Devgen Nv Rnai for control of insects and arachnids
CA2622660C (en) 2005-09-16 2017-11-07 Devgen Nv Transgenic plant-based methods for plant pests using rnai
BRPI0616181B1 (pt) 2005-09-16 2024-03-05 Monsanto Technology Llc Construção de polinucleotídeo isolada, sequência de ribonucleotídeo de fita dupla, microrganismo transgênico, seu método de produção, e métodos para controle de infestação por coleóptero praga, para melhorar o rendimento e a tolerância a estiagem de um cultivo, e para produção de um produto comercial, alimento ou ração
BRPI0615792A2 (pt) 2005-09-16 2009-06-16 Devgen Nv métodos de controle de pestes com base no uso de rnai
EP1971688B1 (en) 2006-01-12 2012-03-14 Devgen NV Dsrna as insect control agent
US8906876B2 (en) 2006-01-12 2014-12-09 Devgen Nv Methods for controlling pests using RNAi
EP2348115A3 (en) 2006-01-12 2012-01-18 deVGen N.V. Transgenic plant-based methods for plant pests using RNAi
US8137933B2 (en) 2008-11-12 2012-03-20 Schering Corporation Mammalian expression vector pUHAB
AU2011322510B2 (en) 2010-10-27 2016-05-05 Devgen Nv Down-regulating gene expression in insect pests
WO2013071047A1 (en) * 2011-11-11 2013-05-16 Children's Medical Center Corporation Compositions and methods for in vitro transcription of rna
EP3938518A4 (en) 2019-03-12 2023-01-11 Terra Bioworks, Inc. EXPRESSION VECTOR
WO2022011082A1 (en) * 2020-07-08 2022-01-13 Stellate Biotherapeutics, Inc. Compositions and methods for producing single stranded dna

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766072A (en) * 1985-07-17 1988-08-23 Promega Corporation Vectors for in vitro production of RNA copies of either strand of a cloned DNA sequence
US5017488A (en) * 1986-04-01 1991-05-21 University Of Medicine And Dentistry Of New Jersey Highly efficient dual T7/T3 promoter vector PJKF16 and dual SP6/T3 promoter vector PJFK15
US5955363A (en) * 1990-01-03 1999-09-21 Promega Corporation Vector for in vitro mutagenesis and use thereof
EP0738779B1 (en) 1990-09-27 2004-05-19 Invitrogen Corporation Direct cloning of PCR amplified nucleic acids
WO1993016170A1 (en) * 1992-02-06 1993-08-19 Gil Ho Choi Genetically engineered transmissible hypovirulence
EP1036846A3 (en) * 1994-02-28 2000-10-18 Shimadzu Corporation Oligonucleotides for detecting bacteria and detection process
US5766891A (en) 1994-12-19 1998-06-16 Sloan-Kettering Institute For Cancer Research Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase
ATE312934T1 (de) * 1995-06-07 2005-12-15 Univ Washington Rekombinant bakterielle system mit umweltbeschränkte lebensfähigkeit
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
FR2782325B1 (fr) * 1998-08-12 2002-05-24 Proteus Procede d'identification de sequences polynucleotidiques et/ou des proteines correspondantes a partir d'un echantillon d'acides nucleiques
GB9827152D0 (en) * 1998-07-03 1999-02-03 Devgen Nv Characterisation of gene function using double stranded rna inhibition
US6326193B1 (en) 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
GB0012233D0 (en) * 2000-05-19 2000-07-12 Devgen Nv Vector constructs

Also Published As

Publication number Publication date
US7358069B2 (en) 2008-04-15
DE60126760T2 (de) 2007-11-15
EP1775345B1 (en) 2010-12-22
EP1285062B1 (en) 2007-02-21
GB2365867A (en) 2002-02-27
GB2365867B (en) 2002-08-14
EP1775345A3 (en) 2007-09-05
EP1285062A1 (en) 2003-02-26
JP2012228256A (ja) 2012-11-22
EP1775345A2 (en) 2007-04-18
DE60126760D1 (de) 2007-04-05
JP5153983B2 (ja) 2013-02-27
JP5645886B2 (ja) 2014-12-24
ATE492638T1 (de) 2011-01-15
AU2001264166A1 (en) 2001-11-26
US7932062B2 (en) 2011-04-26
DE60143718D1 (de) 2011-02-03
JP2004524804A (ja) 2004-08-19
ATE354652T1 (de) 2007-03-15
WO2001088121A1 (en) 2001-11-22
ES2356389T3 (es) 2011-04-07
US20040166580A1 (en) 2004-08-26
GB0112213D0 (en) 2001-07-11
US20080241894A1 (en) 2008-10-02
ES2281420T3 (es) 2007-10-01

Similar Documents

Publication Publication Date Title
GB2365867B (en) Vector constructs
AU144678S (en) Bottle
WO2001088103A3 (en) Compositions and methods for tissue dedifferentiation and regeneration
AU2002332679A1 (en) Targeted nucleic acid constructs and uses related thereto
AU2001294890A1 (en) Pei: dna vector formulations for in vitro and in vivo gene delivery
IL156229A0 (en) Genes associated with mechanical stress, expression products therefrom, and uses thereof
AU153659S (en) Container
AU2002331313A1 (en) Use of l-polynucleotides and derivatives thereof for in vivo imaging
IL156334A0 (en) Methods for the production of multimeric proteins, and related compositions
IL152423A0 (en) Novel vector constructs
EP1219636A3 (en) Modified muteins of erythropoietin (EPO) derived from in vitro or in vivo expression system of microorganisms
AU1074902A (en) Kahalalide f
AU2002365077A8 (en) Methods and products related to non-viral transfection
AU2347002A (en) Modulation of the transcription of pro-inflammatory gene products
PL370703A1 (en) Cell constructs cultured in vitro, preparation and uses
IL161472A0 (en) In vitro micro-organs, and uses related thereto
MXPA03004539A (es) Luciferasas aisladas y uso de las mismas.
CA96704S (en) Bottle
GB2378068B (en) Bipolar differential amplifier
AU6424501A (en) Novel enzyme gene and its expression product
AU1248602A (en) Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids
HUP0300813A3 (en) Genes and proteins, and their uses
GT200000136A (es) Gen de streptomyces avermitilis que dirige la relacion de avermectinas b2 : b1 (2).
ZA200210029B (en) Compositions and methods for the modification of gene expression.
EP1240895B8 (en) Use of alkyl 3-(N-alkylacetamino)propionate derivatives as moisturizing agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)